CAR T-Cell Therapy in ALL: Formidible Challenges Remain – Cancer Network
|
CAR T-Cell Therapy in ALL: Formidible Challenges Remain
Cancer Network “To date, CAR T-cell trials have thus far shown the highest rate of complete and minimal residual disease remission rates of any other agent,” explained Bijal Shah, MD, of Moffitt Cancer Center in Tampa, during the National Comprehensive Cancer Network … |
